Fulranumab

A fully human monoclonal antibody directed against nerve growth factor (NGF) with potential analgesic activity. Upon administration, fulranumab binds to NGF, preventing its binding to and activation of the NGF receptors TrkA and p75NTR. Inhibition of the NGF pathway may prevent the perception of pain and may induce analgesia. NGF, a neurotrophic factor that plays a key role in neuropathic and inflammatory-induced pain, promotes hyperalgesia and allodynia. (NCI Thesaurus)

YOU MAY ALSO LIKE

Fullerene

Source: National Cancer Institute (U.S.)

Full Width at Half Maximum

A measure of resolution used when a system's response y (such as image-displayed activity concentration) to an ideal infinitely narrow spatially distributed…

Full Time Employment

Employed for a standard number of hours of working time, at least 50% or 20 hours per week

Full Term Neonate

An infant born after completion of the normal gestational period.

Full Term Neonatal Stage

The period at birth when a newborn is born after the full gestational period.

Full Sister

A female who shares with her sibling the genetic makeup inherited from both of the biological parents.